AUPH · Aurinia Pharmaceuticals Inc. · Documents
$16.70
+0.21 (+1.27%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$2.22B
Shares
133.05M
Volume · Oct 20
351.59K
Avg daily vol (3M)
966.28K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2020-09-28 | — | |
| 6-K | — | 2020-09-08 | 2020-09-04 | |
| 6-K | — | 2020-08-11 | 2020-06-30 | |
| 6-K | — | 2020-08-11 | — | |
| 6-K | — | 2020-07-23 | — | |
| 6-K | — | 2020-07-22 | — | |
| 6-K | — | 2020-07-21 | — | |
| 6-K | — | 2020-06-22 | — | |
| 6-K | — | 2020-06-09 | — | |
| 6-K | — | 2020-06-05 | — | |
| 6-K | — | 2020-06-03 | — | |
| 6-K | — | 2020-05-26 | 2020-05-25 | |
| 6-K | — | 2020-05-14 | — | |
| 6-K | — | 2020-05-14 | 2020-03-31 | |
| 6-K | — | 2020-04-28 | 2020-05-31 | |
| 6-K | — | 2020-04-27 | — | |
| 6-K | — | 2020-04-20 | — | |
| 6-K | — | 2020-03-19 | 2020-03-18 | |
| 6-K | — | 2020-03-17 | — | |
| 6-K | — | 2020-03-16 | — | |
| 6-K | — | 2020-03-12 | — | |
| 40-F | — | 2020-03-05 | 2019-12-31 | |
| 6-K | — | 2020-03-05 | — | |
| 6-K | — | 2020-02-25 | — |
Showing 101–124 of 124 filings
Key facts
CIK
1600620
CUSIP
05156V102
13F (30d)
19 filings
19 filers
Visit website
Investor relations